These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742 [TBL] [Abstract][Full Text] [Related]
24. Antifibrinolytic drugs for acute traumatic injury. Coats T; Roberts I; Shakur H Cochrane Database Syst Rev; 2004 Oct; (4):CD004896. PubMed ID: 15495129 [TBL] [Abstract][Full Text] [Related]
26. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Tzortzopoulou A; Cepeda MS; Schumann R; Carr DB Cochrane Database Syst Rev; 2008 Jul; (3):CD006883. PubMed ID: 18646174 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures. Huber J; Stanworth SJ; Doree C; Fortin PM; Trivella M; Brunskill SJ; Hopewell S; Wilkinson KL; Estcourt LJ Cochrane Database Syst Rev; 2019 Nov; 11(11):CD012745. PubMed ID: 31778223 [TBL] [Abstract][Full Text] [Related]
28. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Tranexamic Acid in Major Non-Cardiac Surgeries at High Risk for Transfusion: A Systematic Review and Meta-Analysis. Houston BL; Uminski K; Mutter T; Rimmer E; Houston DS; Menard CE; Garland A; Ariano R; Tinmouth A; Abou-Setta AM; Rabbani R; Neilson C; Rochwerg B; Turgeon AF; Falk J; Breau RH; Fergusson DA; Zarychanski R Transfus Med Rev; 2020 Jan; 34(1):51-62. PubMed ID: 31982293 [TBL] [Abstract][Full Text] [Related]
30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
31. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Estcourt LJ; Desborough M; Brunskill SJ; Doree C; Hopewell S; Murphy MF; Stanworth SJ Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009733. PubMed ID: 26978005 [TBL] [Abstract][Full Text] [Related]
32. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. Coppola A; Windyga J; Tufano A; Yeung C; Di Minno MN Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD009961. PubMed ID: 25922858 [TBL] [Abstract][Full Text] [Related]
33. Iron therapy in anaemic adults without chronic kidney disease. Gurusamy KS; Nagendran M; Broadhurst JF; Anker SD; Richards T Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010640. PubMed ID: 25550190 [TBL] [Abstract][Full Text] [Related]
34. Tranexamic acid for the reduction of bleeding during functional endoscopic sinus surgery. Lourijsen E; Avdeeva K; Gan KL; Pundir V; Fokkens W Cochrane Database Syst Rev; 2023 Feb; 2(2):CD012843. PubMed ID: 36808096 [TBL] [Abstract][Full Text] [Related]
35. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323 [TBL] [Abstract][Full Text] [Related]
36. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Ho KM; Ismail H Anaesth Intensive Care; 2003 Oct; 31(5):529-37. PubMed ID: 14601276 [TBL] [Abstract][Full Text] [Related]